Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 8.36%-1.28B | -95.85%-1.4B | -4.09%-712.58M | -24.90%-684.57M | -43.21%-548.08M | 10.68%-382.72M | -37.30%-428.47M | 25.02%-312.07M | -34.97%-416.19M | -23.73%-308.35M |
Net profit before non-cash adjustment | 2.78%-1.21B | -45.48%-1.24B | -61.26%-854.33M | 7.31%-529.78M | -25.62%-571.54M | 14.29%-454.96M | -26.92%-530.84M | -1.09%-418.25M | -55.71%-413.74M | 29.15%-265.71M |
Total adjustment of non-cash items | -144.35%-122.27M | 294.14%275.73M | 133.18%69.96M | -1,266.78%-210.84M | -76.72%18.07M | -24.16%77.63M | -3.45%102.36M | 3,698.82%106.03M | -66.45%2.79M | -93.39%8.32M |
-Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -40.47%6.72M | -10.30%11.28M | -14.58%12.58M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --17.6M | ---- | ---- |
-Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Net exchange gains and losses | -94.59%-12.33M | 68.17%-6.34M | -808.31%-19.9M | -36,616.67%-2.19M | -99.72%6K | 93.53%2.12M | 116.04%1.1M | -146.38%-6.84M | 192.19%14.75M | -513.81%-16M |
-Other non-cash items | -138.98%-109.95M | 213.90%282.06M | 143.07%89.86M | -1,255.04%-208.65M | -76.08%18.06M | -25.44%75.51M | 14.36%101.27M | 481.05%88.55M | -298.00%-23.24M | -89.68%11.74M |
Changes in working capital | 112.05%51.65M | -696.87%-428.47M | 28.07%71.79M | 940.54%56.05M | 200.00%5.39M | ---5.39M | ---- | 102.80%147K | 89.71%-5.24M | ---50.96M |
-Change in receivables | -239.52%-206.18M | ---60.73M | ---- | 940.54%56.05M | 200.00%5.39M | ---5.39M | ---- | 102.80%147K | 89.71%-5.24M | ---50.96M |
-Change in prepaid assets | 170.11%257.82M | -612.28%-367.75M | --71.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0 | 64.90%-2.11M | 20.03%-6M | -100.03%-7.5M | -3.75M | |||||
Interest received (cash flow from operating activities) | 52.38%32K | 23.53%21K | -55.26%17K | -76.10%38K | -46.10%159K | 2.43%295K | 34.58%288K | 18.23%214K | 94.62%181K | 6.90%93K |
Tax refund paid | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M | 0.00%-1.25M |
Other operating cash inflow (outflow) | 0 | 1K | 0 | 4.71M | 0 | 1K | 0 | 0.00%1K | 0.00%1K | 1K |
Operating cash flow | 8.49%-1.28B | -94.35%-1.4B | -4.54%-719.81M | -24.53%-688.57M | -44.11%-552.92M | 10.66%-383.67M | -37.15%-429.43M | 24.96%-313.11M | -34.81%-417.26M | -23.61%-309.51M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,426.42%-13.39M | 15.87%-530K |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---300K | ---- | ---- |
Net changes in other investments | ---- | ---- | --182K | ---- | ---72K | ---- | ---102K | ---- | ---- | ---- |
Investing cash flow | ---- | ---- | --182K | ---- | ---72K | ---- | 66.00%-102K | 97.76%-300K | -2,426.42%-13.39M | 67.34%-530K |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---382.65M | ---- | 258.47%749.99M | --209.22M | ---- | ---- | ---- | ---- |
Net common stock issuance | -31.77%1.54B | 245.48%2.25B | -9.32%652.59M | 388.02%719.69M | -68.83%147.47M | 6,257.32%473.11M | -98.05%7.44M | 3.49%380.83M | -57.01%368M | 181,649.89%856.04M |
Net other fund-raising expenses | ---- | 41.18%18.09M | 40.62%12.81M | 117.31%9.11M | 387.56%4.19M | 760.00%860K | --100K | ---- | --7.15M | ---- |
Financing cash flow | -32.31%1.54B | 703.75%2.27B | -61.20%282.75M | -19.17%728.8M | 31.98%901.66M | 8,958.50%683.19M | -98.02%7.54M | 1.51%380.83M | -56.18%375.15M | 680.75%856.04M |
Net cash flow | ||||||||||
Beginning cash position | 119.28%1.62B | -36.11%737.78M | 3.81%1.15B | 45.66%1.11B | 63.78%763.67M | -47.57%466.28M | 9.11%889.37M | -7.93%815.11M | 173.80%885.36M | -30.18%323.35M |
Current changes in cash | -70.46%258.08M | 299.98%873.69M | -1,186.01%-436.88M | -88.46%40.23M | 16.41%348.67M | 170.98%299.52M | -725.93%-421.99M | 221.48%67.42M | -110.16%-55.5M | 483.53%546M |
Effect of exchange rate changes | 94.59%12.33M | -68.17%6.34M | 808.31%19.9M | 36,616.67%2.19M | 99.72%-6K | -93.53%-2.12M | -116.04%-1.1M | 146.38%6.84M | -192.19%-14.75M | 513.81%16M |
Cash adjustments other than cash changes | ---- | ---- | 0.00%1K | --1K | ---- | ---1K | ---- | 0.00%-1K | -200.00%-1K | --1K |
End cash Position | 16.71%1.89B | 119.28%1.62B | -36.11%737.78M | 3.81%1.15B | 45.66%1.11B | 63.78%763.67M | -47.57%466.28M | 9.11%889.37M | -7.93%815.11M | 173.80%885.36M |
Free cash flow | 8.49%-1.28B | -94.35%-1.4B | -4.54%-719.81M | -24.53%-688.57M | -44.11%-552.92M | 10.66%-383.67M | -37.02%-429.43M | 27.22%-313.41M | -38.90%-430.65M | -22.96%-310.04M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |